Goldenrod Therapeutics, Inc.

CIK 2127885 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Goldenrod Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jun 3, 2026D0002127885-26-000001